190 related articles for article (PubMed ID: 34363022)
21. Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation.
Ding Z; Liu X; Liu Y; Zhang J; Huang X; Yang X; Yao L; Cui G; Wang D
Mol Carcinog; 2015 May; 54(5):405-15. PubMed ID: 24347226
[TBL] [Abstract][Full Text] [Related]
22. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
Zhu X; Shen H; Yin X; Long L; Chen X; Feng F; Liu Y; Zhao P; Xu Y; Li M; Xu W; Li Y
Oncotarget; 2017 Jun; 8(24):39154-39166. PubMed ID: 28388577
[TBL] [Abstract][Full Text] [Related]
23. The FOXC1/FBP1 signaling axis promotes colorectal cancer proliferation by enhancing the Warburg effect.
Li Q; Wei P; Wu J; Zhang M; Li G; Li Y; Xu Y; Li X; Xie D; Cai S; Xie K; Li D
Oncogene; 2019 Jan; 38(4):483-496. PubMed ID: 30171256
[TBL] [Abstract][Full Text] [Related]
24. ID1 confers cancer cell chemoresistance through STAT3/ATF6-mediated induction of autophagy.
Meng J; Liu K; Shao Y; Feng X; Ji Z; Chang B; Wang Y; Xu L; Yang G
Cell Death Dis; 2020 Feb; 11(2):137. PubMed ID: 32080166
[TBL] [Abstract][Full Text] [Related]
25. TRIM47 accelerates aerobic glycolysis and tumor progression through regulating ubiquitination of FBP1 in pancreatic cancer.
Li L; Yu Y; Zhang Z; Guo Y; Yin T; Wu H; Yang M
Pharmacol Res; 2021 Apr; 166():105429. PubMed ID: 33529753
[TBL] [Abstract][Full Text] [Related]
26. MiR-3666 serves as a tumor suppressor in ovarian carcinoma by down-regulating AK4 via targeting STAT3.
Tan H; Wu C; Huang B; Jin L; Jiang X
Cancer Biomark; 2021; 30(4):355-363. PubMed ID: 33361582
[TBL] [Abstract][Full Text] [Related]
27. TRIM47 promotes ovarian cancer cell proliferation, migration, and invasion by activating STAT3 signaling.
Wang X; Fu Y; Xing Y
Clinics (Sao Paulo); 2022; 77():100122. PubMed ID: 36288633
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells.
Burke WM; Jin X; Lin HJ; Huang M; Liu R; Reynolds RK; Lin J
Oncogene; 2001 Nov; 20(55):7925-34. PubMed ID: 11753675
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer.
Jia ZH; Jia Y; Guo FJ; Chen J; Zhang XW; Cui MH
PLoS One; 2017; 12(8):e0183622. PubMed ID: 28859117
[TBL] [Abstract][Full Text] [Related]
30. Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer.
Chen M; Zhang J; Li N; Qian Z; Zhu M; Li Q; Zheng J; Wang X; Shi G
PLoS One; 2011; 6(10):e25564. PubMed ID: 22039417
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo.
Zhang X; Liu P; Zhang B; Mao H; Shen L; Ma Y
Int J Mol Med; 2013 Sep; 32(3):623-8. PubMed ID: 23828376
[TBL] [Abstract][Full Text] [Related]
32. Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 Pathway.
Zhao X; Cheng Z; Wang J
Med Sci Monit; 2018 Nov; 24():8088-8095. PubMed ID: 30416194
[TBL] [Abstract][Full Text] [Related]
33. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis.
Zheng B; Geng L; Zeng L; Liu F; Huang Q
Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
[TBL] [Abstract][Full Text] [Related]
34. Retinoic Acid-Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer.
Cao D; Qi Z; Pang Y; Li H; Xie H; Wu J; Huang Y; Zhu Y; Shen Y; Zhu Y; Dai B; Hu X; Ye D; Wang Z
Cancer Res; 2019 May; 79(10):2604-2618. PubMed ID: 30808674
[TBL] [Abstract][Full Text] [Related]
35. Loss of FBP1 facilitates aggressive features of hepatocellular carcinoma cells through the Warburg effect.
Yang J; Wang C; Zhao F; Luo X; Qin M; Arunachalam E; Ge Z; Wang N; Deng X; Jin G; Cong W; Qin W
Carcinogenesis; 2017 Feb; 38(2):134-143. PubMed ID: 27742690
[TBL] [Abstract][Full Text] [Related]
36. Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells.
Han Z; Feng J; Hong Z; Chen L; Li W; Liao S; Wang X; Ji T; Wang S; Ma D; Chen G; Gao Q
Biochem Biophys Res Commun; 2013 May; 435(2):188-94. PubMed ID: 23665025
[TBL] [Abstract][Full Text] [Related]
37. FBP1 loss contributes to BET inhibitors resistance by undermining c-Myc expression in pancreatic ductal adenocarcinoma.
Wang B; Fan P; Zhao J; Wu H; Jin X; Wu H
J Exp Clin Cancer Res; 2018 Sep; 37(1):224. PubMed ID: 30201002
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of STAT3 by shRNA inhibits the growth of CAOV3 ovarian cancer cell line in vitro and in vivo.
Huang F; Tong X; Fu L; Zhang R
Acta Biochim Biophys Sin (Shanghai); 2008 Jun; 40(6):519-25. PubMed ID: 18535750
[TBL] [Abstract][Full Text] [Related]
39. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
[TBL] [Abstract][Full Text] [Related]
40. Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3).
Kandala PK; Srivastava SK
BMC Med; 2012 Jan; 10():9. PubMed ID: 22280969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]